US OTC drugmakers welcome medication abuse campaign

6 August 2006

The US Consumer Healthcare Products Association has offered its support for the US Congress's recent efforts to examine the problem of medicine abuse. The House of Representatives' Reform Subcommittee on Criminal Justice, Drug Policy and Human Resources heard from Stephen Pasierb, president of the Partnership for a Drug-Free America, who highlighted the CHPA's campaign against the abuse of over-the-counter remedies. The CHPA is running a public awareness campaign, the Rx and OTC Medicine Abuse Education Campaign, aimed at parents.

In a statement, Linda Suydam, the CHPA's president, said: "it's important that parents understand that their children may be abusing the very medicines that we use to safely and effectively treat common everyday ailments, by taking exceedingly higher doses than what is recommended for treatment."

Law intended to "cut off" misused medication supply

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight